|
NUF2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.249600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.694800E-01 |
| Normal-vs-Stage2 |
1.096440E-01 |
| Normal-vs-Stage3 |
9.729200E-01 |
| Normal-vs-Stage4 |
6.082600E-01 |
| Stage1-vs-Stage2 |
2.433000E-04 |
| Stage1-vs-Stage3 |
9.953400E-01 |
| Stage1-vs-Stage4 |
3.642200E-01 |
| Stage2-vs-Stage3 |
2.260600E-03 |
| Stage2-vs-Stage4 |
1.903920E-03 |
| Stage3-vs-Stage4 |
4.374000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.830800E-01 |
| Normal-vs-AfricanAmerican |
4.069600E-01 |
| Normal-vs-Asian |
8.824000E-01 |
| Caucasian-vs-AfricanAmerican |
1.807170E-01 |
| Caucasian-vs-Asian |
9.777000E-01 |
| AfricanAmerican-vs-Asian |
1.982370E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.291800E-01 |
| Normal-vs-Female |
8.712400E-01 |
| Male-vs-Female |
5.317800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.904600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.063800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.309800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.016350E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.33640000000857E-05 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.907800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.904380E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.690100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.413700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.642390E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.766000E-01 |
| Classical-VS-Follicular |
1.96230000026887E-07 |
| Classical-VS-Other |
6.257800E-01 |
| Classical-VS-Normal |
7.385800E-01 |
| Tall-VS-Follicular |
7.480600E-03 |
| Tall-VS-Other |
5.513800E-01 |
| Tall-VS-Normal |
7.012000E-01 |
| Follicular-VS-Other |
2.281200E-01 |
| Follicular-VS-Normal |
1.291810E-01 |
| Other-VS-Normal |
7.610200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.217000E-01 |
| Normal-vs-N1 |
8.547800E-01 |
| N0-vs-N1 |
2.349200E-01 |
|
|
